Detection of apolipoprotein E phenotype in unconcentrated cerebrospinal fluid

Journal of Clinical Laboratory Analysis

Volumn 17, Issue 1, 2003, Pages 18-21

  Mehta, Pankaj D ^a   Patrick, B A ^a   Pirttila, T ^b   Coyle, P K ^c   Aisen, P S ^d  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c STONY BROOK UNIVERSITY   (United States)

^d GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Apolipoprotein E phenotype; Cerebrospinal fluid; Immunoblotting; Isoelectric focusing; Neurological diseases

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DNA POLYMORPHISM; HUMAN; IMMUNOBLOTTING; ISOELECTRIC FOCUSING; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PHENOTYPE; PROTEIN ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEINS E; DNA; HUMANS; ISOELECTRIC FOCUSING; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 0037271236     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcla.10063     Document Type: Article

References (24)

1. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-630.
2. Rall Jr SC, Weisgraber KH, Mahley RW. Human apolipoprotein E. The complete amino acid sequence. J Biol Chem 1982;257:4171-4178.
3. Paik YK, Chang DJ, Reardon CA, Davies GE, Mahley RW, Taylor JM. Nucleotide sequence and structure of the human apolipoprotein E gene. Proc Natl Acad Sci U S A 1984;82:3445-3449.
4. Roheim PS, Carey M, Forte T. Apolipoproteins in human cerebrospinal fluid. Proc Natl Acad Sci U S A 1979;76:4646-4649.
5. Lehtimaki T, Pirttila T, Mehta PD, Wisniewski HM, Frey H, Nikkari T. Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease. Hum Genet 1995;95:39-42.
6. Mayeux R, Saunders AM, Shea S, et al. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. N Engl J Med 1998;338:505-511.
7. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
8. Zerr I, Helmhold M, Poser S, Armstrong VW, Weber T. Apolipoprotein E phenotype frequency and cerebrospinal fluid concentration are not associated with Creutzfeld-Jakob disease. Arch Neurol 1986;53:1233-1238.
9. Tang G, Xie H, Xu L, Hao Y, Lin D, Ren D. Genetic study of Apolipoprotein gene, alpha-1-chymotrypsin gene in sporadic Parkinson disease. Am J Med Genet 2002;114:446-449.
10. Chapman J, Vinokurov S, Achiron A. APOE genotype is a major predictor of long-term progression of disability in MS. Neurology 2001;56:312-316.
11. Evangelou N, Jackson M, Beeson D. Association of the APOE ε4 allele with disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatry 1999;67:203-205.
12. Hackler R, Schoffer JR, Motzny S, et al. Rapid determination of apolipoprotein E phenotypes from whole plasma by automated isoelectric focusing using PhasSystem™ and immunofixation. J Lipid Res 1994;35:153-158.
13. Kamboh MI, Ferell RE, Kottke B. Genetic studies of human apolipoproteins. V. A novel rapid procedure to screen apolipoprotein E polymorphism. J Lipid Res 1988:29:1535-1543.
14. Kataoka S, Paidi M, Howard BV. Simiplified isoelectric focusing/immunoblotting determination of apolipoprotein E phenotype. Clin Chem 1994;40:11-13.
15. Hill JS, Pritchard PH. Improved phenotyping of apolipoprotein E: application to population frequency distribution. Clin Chem 1990;36:1871-1874.
16. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31:545-548.
17. Oliveri RL, Cittadella R, Sibilia G. APOE and risk of cognitive impairment in multiple sclerosis. Acta Neuro Scand 1999;100:290-295.
18. Utermann G, Hees M, Steinmetz A. Polymorphism of apo E and occurrence of dysbetalipoproteinemia in man. Nature 1977;269:604-607.
19. Zannis VI. Genetic polymorphism in human apolipoprotein E. Methods Enzymol 1986;128:823-851.
20. Adiloglu AK, Gurakur-Osborne A, Prete PE. Standardized determination of apolipoprotein E phenotypes by simplified isoelectric focusing/immunoblotting in plasma and synovial fluid. Clin Chim Acta 1998;273:99-102.
21. Dupuy A, Badiou S, Ritchie K. Discrepancies between apolipoprotein E phenotyping and genotyping in the elderly. Clin Chem 2001;39:405-413.
22. Wardell MR, Brennan SO, Janus ED, Fraser R, Carell RW. Apolipoprotein E2-Christchurch (136 Arg Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia. J Clin Invest 1987;80:483-490.
23. Ferri C, Sciacca FL, Veglia F. APOE ε2-4 and -491 polymorphisms are not associated with MS. Neurology 1999;53:888-889.
24. Weatherby SJM. No association between the APOE ε4 allele and outcome and susceptibility in primary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 2000;68:532.